Difference between revisions of "WSI21-23-Case-2"

From MGH Learn Pathology
(Edited automatically from page WSI21-23.)
(Automatic edit to upgrade to new templates)
Line 1: Line 1:
−
{{dziCase
+
{{ServiceRequestCase
−
|qc=yes
+
|identifier=WSI21-23-Case-2
−
|qcuser=Aja51
+
|intent=order
−
|qctime=Feb 11, 2021 21:35:10
+
|category=409073007
−
|order_date=February 11, 2021 03:17:13 PM
+
|priority=routine
−
|user=Aja51
+
|orderDetail=case
−
|dziorder=WSI21-23
+
|locationCode=learn
−
|case_id=2
+
|basedOn=WSI21-23
−
|publish_timestamp=Choose_date 13:00
+
|code=faculty
−
|clinical_hx=Not provided.
+
|supportingInfo=A. LUNG, LEFT LOWER LOBE, WEDGE RESECTION (C1, C3)
−
|case_diagnosis=A. LUNG, LEFT LOWER LOBE, WEDGE RESECTION (C1, C3)
 
 
Metastatic kinase fusion-related thyroid carcinoma to the lung (2.1 cm, by report), multinodular, with multifocal vessel involvement.
 
Metastatic kinase fusion-related thyroid carcinoma to the lung (2.1 cm, by report), multinodular, with multifocal vessel involvement.
 
Note: The tumor morphology is distinct with a follicular growth pattern and glomeruloid structures. These findings are seen in association with kinase-fusion related carcinomas.
 
Note: The tumor morphology is distinct with a follicular growth pattern and glomeruloid structures. These findings are seen in association with kinase-fusion related carcinomas.
Line 17: Line 16:
 
C. BRAIN, RIGHT OCCIPITAL, EXCISIONAL BIOPSY (B1)
 
C. BRAIN, RIGHT OCCIPITAL, EXCISIONAL BIOPSY (B1)
 
Metastatic kinase fusion-related thyroid carcinoma (0.6 cm, in aggregate).
 
Metastatic kinase fusion-related thyroid carcinoma (0.6 cm, in aggregate).
 +
|reasonCode=Not provided.
 +
|subject=public
 +
|performer=Pms36
 +
|authoredOn=February 11, 2021 03:17:13 PM
 +
|requester=Aja51
 +
|sequence=2
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=February 11, 2021 03:17:13 PM
+
|basedOn=WSI21-23-Case-2
−
|user=Aja51
+
|type=image
−
|source_filename=Z0FBQUFBQmdKVXM3NXdkSWM2R3ZldDB2NFZWbDlOZTEzb2d6RW9GUE1WQWY2TmwtUjlDcDBIOVpNWExrajdRN3hMc2FWOFNEby0tVDlmdE5YTnNFZ1RBLUZnVUR5YlBfcUc4Z3J5WVpBTW1YcmhadUc4dy1nU0E9
+
|view=show
−
|slide_stain=H&E
+
|partOf=WSI21-23
−
|slide_anatomy=Show
+
|frames=1
 +
|reasonCode=H&E
 +
|identifier=WSI21-23-Case-2_1
 +
|createdDateTime=February 11, 2021 03:17:13 PM
 +
|operator=Aja51
 +
|subject=Z0FBQUFBQmdKVXM3NXdkSWM2R3ZldDB2NFZWbDlOZTEzb2d6RW9GUE1WQWY2TmwtUjlDcDBIOVpNWExrajdRN3hMc2FWOFNEby0tVDlmdE5YTnNFZ1RBLUZnVUR5YlBfcUc4Z3J5WVpBTW1YcmhadUc4dy1nU0E9
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=February 11, 2021 03:17:13 PM
+
|basedOn=WSI21-23-Case-2
−
|user=Aja51
+
|type=image
−
|source_filename=Z0FBQUFBQmdKVXM3WXJ3T1FFRTJNYjdJeTlsMDhyazRfM2NvazB3d1FSaFlLUXkxNWV4SEdaYUE3T1cxdG56V2NvaUFFT2M0elVSY2owa3FRcWcxRVZUVzdmcEtlelFfMEJyRUdlbGtMSkJFOE1ZT090dXdUR009
+
|view=show
−
|slide_stain=H&E
+
|partOf=WSI21-23
−
|slide_anatomy=Show
+
|frames=2
 +
|reasonCode=H&E
 +
|identifier=WSI21-23-Case-2_2
 +
|createdDateTime=February 11, 2021 03:17:13 PM
 +
|operator=Aja51
 +
|subject=Z0FBQUFBQmdKVXM3WXJ3T1FFRTJNYjdJeTlsMDhyazRfM2NvazB3d1FSaFlLUXkxNWV4SEdaYUE3T1cxdG56V2NvaUFFT2M0elVSY2owa3FRcWcxRVZUVzdmcEtlelFfMEJyRUdlbGtMSkJFOE1ZT090dXdUR009
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=February 11, 2021 03:17:13 PM
+
|basedOn=WSI21-23-Case-2
−
|user=Aja51
+
|type=image
−
|source_filename=Z0FBQUFBQmdKVXM2ZGZIYnVid1hwa0htbTBQcEJSSUFnMVFoMVJ5UUNCU0JQUXoxd0NlUEpqLUF2YXQwdGg5VmdBWG9nUy1BZ0xJTlJqdVZ1Vk1mV1lGZWNyQ1ZVRng4YlQ2X3ZUc05NWlQ1U3FmY1dzNVVKS0k9
+
|view=show
−
|slide_stain=H&E
+
|partOf=WSI21-23
−
|slide_anatomy=Show
+
|frames=3
 +
|reasonCode=H&E
 +
|identifier=WSI21-23-Case-2_3
 +
|createdDateTime=February 11, 2021 03:17:13 PM
 +
|operator=Aja51
 +
|subject=Z0FBQUFBQmdKVXM2ZGZIYnVid1hwa0htbTBQcEJSSUFnMVFoMVJ5UUNCU0JQUXoxd0NlUEpqLUF2YXQwdGg5VmdBWG9nUy1BZ0xJTlJqdVZ1Vk1mV1lGZWNyQ1ZVRng4YlQ2X3ZUc05NWlQ1U3FmY1dzNVVKS0k9
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=February 11, 2021 03:17:13 PM
+
|basedOn=WSI21-23-Case-2
−
|user=Aja51
+
|type=image
−
|source_filename=Z0FBQUFBQmdKVXM2dUhfaVdEQ2ducEE1Q194SkJqVWxoSGZQX0gxQ24zQzMtRWN4ZjVVMl9tbzFNRkk4OHY2eGJsN19TMmNxemJXUG1GNXNIZzN0UnFLaE9qZTd5V3RTdm5XNWRwRDN3bVVIWjRBVk1JYmpuRWM9
+
|view=show
−
|slide_stain=H&E
+
|partOf=WSI21-23
−
|slide_anatomy=Show
+
|frames=4
 +
|reasonCode=H&E
 +
|identifier=WSI21-23-Case-2_4
 +
|createdDateTime=February 11, 2021 03:17:13 PM
 +
|operator=Aja51
 +
|subject=Z0FBQUFBQmdKVXM2dUhfaVdEQ2ducEE1Q194SkJqVWxoSGZQX0gxQ24zQzMtRWN4ZjVVMl9tbzFNRkk4OHY2eGJsN19TMmNxemJXUG1GNXNIZzN0UnFLaE9qZTd5V3RTdm5XNWRwRDN3bVVIWjRBVk1JYmpuRWM9
 +
|modality=mrxs
 
}}
 
}}

Revision as of 12:06, March 9, 2022

WSI21-23-Case-2
Not provided.
A. LUNG, LEFT LOWER LOBE, WEDGE RESECTION (C1, C3)

Metastatic kinase fusion-related thyroid carcinoma to the lung (2.1 cm, by report), multinodular, with multifocal vessel involvement. Note: The tumor morphology is distinct with a follicular growth pattern and glomeruloid structures. These findings are seen in association with kinase-fusion related carcinomas. B. RIGHT UPPER LOBE MASS, WEDGE RESECTION (A2) Metastatic kinase-fusion related thyroid carcinoma (1.8 cm, by report). Note: There is a dominant tumor nodule with adjacent, discrete tumor foci present in large blood vessels. C. BRAIN, RIGHT OCCIPITAL, EXCISIONAL BIOPSY (B1)

Metastatic kinase fusion-related thyroid carcinoma (0.6 cm, in aggregate).
December 31, 1969 7:00:00 PM







Retrieved from "https://learn.mghpathology.org/index.php?title=WSI21-23-Case-2&oldid=80282"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital